Cancer Research UK, Cytovation and the Norwegian Cancer Society have signed an agreement to bring Cytovation’s lead asset, CY-101, into a multi-national Phase 2 clinical trial for patients with adrenocortical carcinoma (ACC).
This rare and aggressive cancer, which affects the adrenal glands, has limited treatment options and an urgent need for new therapies.
London, January 23, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for NeoPhore Limited and is pleased to announce the placement of Michael Shih as Chief Executive Officer (CEO) and Board of Director.
https://www.globenewswire.com/news-release/2025/01/22/3013431/0/en/Cond…
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
• Award winning Agility Life Sciences brings a proven track record in drug formulation for a number of pharmaceutical and biotechnology clients.
Cambridge, UK, 20 January 2025: Metrion Biosciences (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced it has been listed in The Sunday Times 100 Tech, Britain's fastest-growing private technology companies. The inaugural feature, published 19th January, highlights the UK’s fastest-growing private companies developing or selling unique, proprietary technologies, and is backed by Singer Capital Markets, HSBC Innovation Banking and BDO.
About RxCelerate
The RxCelerate group is an out-sourced drug development platform specialising in the design and delivery of complete drug discovery and development programs and project management for our clients spanning initial ideas through to Phase II clinical studies.
The Role
RxCelerate is seeking a skilled Laboratory Manager to oversee the biological and chemical laboratories, ensuring quality, safety, and efficiency in all laboratory operations.
• £500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosis
• Programme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet need
Pioneer Group, the life science infrastructure and venture building specialist, has joined forces with Innovate UK, The Medical Research Council (MRC) and AstraZeneca, to deliver the AI in Health Accelerator 2024/2025 Programme.
The Accelerator is designed to help entrepreneurs confidently market their AI-driven healthcare solutions and accelerate novel technology development time to market. The partners will collaborate across all elements of the Accelerator Programme, including its design and operation.
Hoddesdon, UK
We are looking for:
A Technical Project Lead (Drug Product Development), a subject matter expert, to provide technical leadership in drug product development and support the execution of formulation development programs involving phase-appropriate formulations and processes to support clinical studies or client needs.
Do your company videos get less than 100 views? It could be that customers aren’t watching the whole thing. Customers leaving a video early shows they’re not engaged with your brand’s message. That’s got to hurt. It certainly hurts your SEO.
Starting something new is hard – particularly within the fast-moving life science sector. Step forward Accelerate@Babraham, the Babraham Research Campus’ bio-incubator, founded out of a desire to support and nurture early-stage ventures; bringing to bear an unrivalled network of experts, mentors and investors and data-driven, comprehensive business analysis and support to equip these young enterprises with the skills, confidence and network connections to enable success.